GrO2 SRL
The score of GrO2 shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity -36 % Total assets -35 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
GrO2's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 01 Jun 2026
- Year ended 31 Dec 2024filed on 02 Jun 2025
- Year ended 31 Dec 2023filed on 06 Jun 2024
GrO2's financial analysis
- Solvency93.3%sector median: 60.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of GrO2
GrO2's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0792.145.055
- VAT number
- BE0792145055
- Peppol
- Registered · 0208:0792145055 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 06 Oct 2022
- Registered office
- 2400 Mol
- Latest accounts
- 2025 · filed on 01 Jun 2026
- Activity
- Research and experimental development on other natural sciences and engineering (NACE 72109)
GrO2 (SRL) has been based in Mol since 2022, active in: research and experimental development on other natural sciences and engineering. For 2025, it reports a net loss of 4,807 € and equity of 20,856 €; its revenue is not published. Its solvency stands at 93.3%, above the median of its sector (60.4%).
Companies similar to GrO2
Companies in the same business, of comparable size and area, outside its group.
- Alanine Research and experimental development on natural sciences and engineering Lasne · balance sheet 28,321 €
- IQVIA Cancer Research Research and experimental development on natural sciences and engineering Zaventem · balance sheet €1.07m
- Bimsconsult Research and experimental development on natural sciences and engineering Auderghem · balance sheet 463,296 €
- OPO Research and experimental development on natural sciences and engineering Thimister-Clermont · balance sheet 22,711 €
- Microbio Research and experimental development on natural sciences and engineering Berlaar · balance sheet 24,493 €
- ACT-W Research and experimental development on natural sciences and engineering Nandrin · balance sheet 27,136 €
- Jacobs Consultancy Research and experimental development on natural sciences and engineering Antwerp · balance sheet 16,077 €
- Evalchemist Research and experimental development on natural sciences and engineering Lasne · balance sheet 15,464 €
Frequently asked questions about GrO2
What is the revenue of GrO2?
GrO2 files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of GrO2?
In Belgium, the VAT number is the company number prefixed with BE: BE0792145055 for GrO2, if the company is VAT-registered. Its company number (CBE) is 0792.145.055.
Where is the registered office of GrO2?
According to the CBE register, the registered office of GrO2 is in 2400 Mol.
What is the equity of GrO2?
At the close of the 2025 financial year, the equity of GrO2 amounts to 20,856 €, a solvency of 93.3% of total assets.
Who manages GrO2?
The register lists 2 active mandates at GrO2. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of GrO2
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →